A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab′)2 fragments (5S IVIG) and Fc fragments. Evidence for post‐transcriptional IL‐2 modulation
Open Access
- 1 February 1997
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 90 (2), 212-218
- https://doi.org/10.1046/j.1365-2567.1997.d01-2148.x
Abstract
During the past few decades intravenous immunoglobulin (IVIG) has been used successfully in the treatment of various immunoregulatory disorders. Treatment results have been attributed to immunomodulation mainly via Fc receptors or by anti‐idiotypic antibodies to disease‐causing autoantibodies. From the present study it is clearly evident that 7S IVIG (intact immunoglobulin) as well as 5S IVIG [ F(ab′)2 fragments] and Fc fragments have a potent immunomodulatory capacity. We demonstrate that mainly 7S IVIG inhibits alloantigen‐induced T‐cell proliferation and generation of cytotoxic T lymphocytes. Reduced interleukin‐2 (IL‐2) protein levels in culture supernatants of IVIG‐supplemented mixed lymphocyte reactions (MLR) but unchanged IL‐2 mRNA levels strongly argue in favour of a post‐transcriptional interference of IVIG with cytokines and/or cytokine production. Interferon‐γ (IFN‐γ), soluble IL‐2 receptor (sIL‐2R) and monokines such as IL‐1β, IL‐6, IFN‐α and tumour necrosis factor (TNF‐α) were not affected by IVIG supplementation to MLR. Fc fragments were superior to F(ab′)2‐containing IVIG (5S and 7S IVIG) in inhibiting lectin stimulation of peripheral blood mononuclear cells (PBMC), whereas natural killer (NK) cytotoxicity was primarily inhibited by Fc‐bearing IVIG (7S IVIG and Fc fragments), suggesting multiple mechanisms of IVIG immunomodulatory activity.Keywords
This publication has 31 references indexed in Scilit:
- Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]Journal of Clinical Investigation, 1993
- Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Journal of Clinical Investigation, 1990
- THE USE AND MECHANISMS OF ACTION OF INTRAVENOUS IMMUNOGLOBULIN: AN UPDATEBritish Journal of Haematology, 1989
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell linesInternational Journal of Cancer, 1986
- Use of Donor-Specific T-Cell Lines for Monitoring of Human Allograft RecipientsPathobiology, 1986
- EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA: Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells?The Lancet, 1983
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- Dysfunctions of Pokeweed Mitogen-stimulated T and B Lymphocyte Responses Induced by Gammaglobulin TherapyJournal of Clinical Investigation, 1981
- The effect of Fc fragments of IgG on human mononuclear cell responsesCellular Immunology, 1980